SLC1A1 and early-onset autosomal dominant Alzheimer disease: Several studies have demonstrated that dysregulation of EAAT3 expression or function can lead to various neurological disorders, including Alzheimer's disease, Parkinson's disease, depression, and schizophrenia.40, 41